BusinessEarth Science Tech Strengthens Advisory Board with Four Distinguished Scientists and Doctors to Expand the Pharmaceutical & Nutraceutical Development of Cannabinoids' Therapeutic Indications, R&D, Technology, IP and TreatmentsBy Nasdaq OMXFeb 9, 2017, 12:45 PM UTC
BusinessTonix Pharmaceuticals to Present Breakthrough Therapy Designated-PTSD Program and Corporate Update at the 2017 BIO CEO & Investor ConferenceBy Nasdaq OMXFeb 9, 2017, 12:02 PM UTC
BusinessTonix Pharmaceuticals to Present Breakthrough Therapy Designated-PTSD Program and Corporate Update at the 2017 BIO CEO & Investor ConferenceBy Nasdaq OMXFeb 9, 2017, 12:01 PM UTC
BusinessAbeona Therapeutics Enrolls First High Dose Subject in Ongoing Phase 1/2 Gene Therapy Clinical Trial in Sanfilippo Syndrome Type ABy Nasdaq OMXFeb 1, 2017, 12:43 PM UTC
BusinessUSF Researcher Develops Therapeutic Vaccine to Combat Alzheimer’s Disease and Neurodegenerative DisordersBy Nasdaq OMXJan 30, 2017, 11:00 AM UTC
BusinessEarth Science Tech, Inc. (OTC: ETST) Finalizes Joint Venture with Karmavore Superfoods and Signs New CMO, Sergio CastilloBy Nasdaq OMXJan 25, 2017, 12:45 PM UTC
BusinessEarth Science Tech, Inc. (OTC: ETST) Signs Marketing & Media Agreement with Pearls of Health and Appoints Gabriel Aviles as Chief Sales Officer (CSO).By Nasdaq OMXJan 9, 2017, 12:45 PM UTC
